Colon-specific immune microenvironment regulates cancer progression versus rejection

Immunotherapies have achieved clinical benefit in many types of cancer but remain limited to a subset of patients in colorectal cancer (CRC). Resistance to immunotherapy can be attributed in part to tissue-specific factors constraining antitumor immunity. Thus, a better understanding of how the colo...

Descripción completa

Detalles Bibliográficos
Autores principales: Trimaglio, Giulia, Tilkin-Mariamé, Anne-Françoise, Feliu, Virginie, Lauzéral-Vizcaino, Françoise, Tosolini, Marie, Valle, Carine, Ayyoub, Maha, Neyrolles, Olivier, Vergnolle, Nathalie, Rombouts, Yoann, Devaud, Christel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458593/
https://www.ncbi.nlm.nih.gov/pubmed/32923152
http://dx.doi.org/10.1080/2162402X.2020.1790125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458593/
https://www.ncbi.nlm.nih.gov/pubmed/32923152
http://dx.doi.org/10.1080/2162402X.2020.1790125

Ejemplares similares